The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Levakov S.A.

Kafedra akusherstva i ginekologii Instituta povysheniia kvalifikatsii, zhenskaia konsul'tatsiia MSCh #170 Federal'nogo mediko-biologicheskogo agentstva Rossii, Moskva

Sheshukova N.A.

Kafedra akusherstva i ginekologii fakul'teta poslevuzovskogo professional'nogo obrazovaniia vracheĭ Moskovskoĭ meditsinskoĭ akademii im. I.M. Sechenova

Bol'shakova O.V.

I.M. Sechenov First Moscow State Medical University, Moscow, Russia, 119991, City clinical hospital №5, Moscow, Russia, 107014

Obukhova E.A.

FSAEI HE I.M.Sechenov First MSMU MOH Russia, department of Obstetrics and Gynecology, Trubetskaya street 8/2, Moscow, 119991, Russian Federation

The treatment of patients with endometrial hyperplasia

Authors:

Levakov S.A., Sheshukova N.A., Bol'shakova O.V., Obukhova E.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2017;23(2): 33‑36

Read: 15857 times


To cite this article:

Levakov SA, Sheshukova NA, Bol'shakova OV, Obukhova EA. The treatment of patients with endometrial hyperplasia. Russian Journal of Human Reproduction. 2017;23(2):33‑36. (In Russ.)
https://doi.org/10.17116/repro201723233-36

Recommended articles:
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
The possibilities of realizing reproductive function in women with endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):98-105

References:

  1. Royal College of Obstetricians and Gynaecologists. Management of Endometrial Hyperplasia. RCOG/BSGE Green-top Guidelineю 2016 February;67.
  2. Reed SD, Voigt LF, Newton KM, Garcia RH, Allison HK, Epplein M, Jordan D, Swisher E, Weiss NS. Progestin therapy of complex endometrial hyperplasia with and without atypia. Obstet Gynecol. 2009;113:655-662. doi:10.1097/aog.0b013e318198a10a
  3. Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL. Management of endometrial precancers. Obstet Gynecol. 2012;120:1160-1175. doi:10.1097/AOG.0b013e31826bb121
  4. Dolapcioglu K, Boz A, Baloglu A. The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study. Clin Exp Obstet Gynecol. 2013;40:122-126.
  5. Zaino R, Carinelli SG, Ellenson LH. Tumours of the uterine Corpus: epithelial Tumours and Precursors. Lyon: WHO Press.2014;125-126.
  6. Emons G, Beckmann MW, Schmidt D, Mallmann P. New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015;75(2):135-136. doi:10.1055/s-0034-1396256

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.